RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.94B
AUM Growth
-$52.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1 +$111M
2 +$29.3M
3 +$27.4M
4
HNGE
Hinge Health
HNGE
+$15.5M
5
TYRA icon
Tyra Biosciences
TYRA
+$14.9M

Top Sells

1 +$58.6M
2 +$46.8M
3 +$45.6M
4
URGN icon
UroGen Pharma
URGN
+$35.5M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$33.1M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOWL icon
51
Werewolf Therapeutics
HOWL
$46.1M
$7.28M 0.12%
6,681,307
+536,426
BBNX
52
Beta Bionics
BBNX
$1.3B
$7.28M 0.12%
500,000
CTMX icon
53
CytomX Therapeutics
CTMX
$698M
$6.04M 0.1%
2,661,331
+1,661,331
TXG icon
54
10x Genomics
TXG
$2.3B
$5.5M 0.09%
475,343
-1,468,904
SRZN icon
55
Surrozen
SRZN
$137M
$5.39M 0.09%
602,626
-76,504
WGS icon
56
GeneDx Holdings
WGS
$4.76B
$5.36M 0.09%
+58,044
AVTX icon
57
Avalo Therapeutics
AVTX
$302M
$4.66M 0.08%
932,973
-34,027
ACET icon
58
Adicet Bio
ACET
$95.6M
$4.6M 0.08%
7,541,000
MBX
59
MBX Biosciences
MBX
$1.53B
$4.31M 0.07%
377,841
-1,133,493
TARA icon
60
Protara Therapeutics
TARA
$259M
$3.15M 0.05%
1,039,295
-2,360,705
NAMSW icon
61
NewAmsterdam Pharma Warrant
NAMSW
$137M
$2.67M 0.04%
333,333
ACHC icon
62
Acadia Healthcare
ACHC
$1.57B
$2.03M 0.03%
89,262
-127,738
IFRX icon
63
InflaRx
IFRX
$77.9M
$1.56M 0.03%
+1,973,233
INSM icon
64
Insmed
INSM
$45B
-200,000
ITOS
65
DELISTED
iTeos Therapeutics
ITOS
-3,649,057
KURA icon
66
Kura Oncology
KURA
$1B
-4,004,610
ACRS icon
67
Aclaris Therapeutics
ACRS
$286M
-4,666,667
ALEC icon
68
Alector
ALEC
$135M
-9,695,228
APGE icon
69
Apogee Therapeutics
APGE
$4.78B
-1,569,491
ATXS icon
70
Astria Therapeutics
ATXS
$720M
-5,105,213
BCYC
71
Bicycle Therapeutics
BCYC
$494M
-1,093,477
DAWN icon
72
Day One Biopharmaceuticals
DAWN
$919M
-5,755,577
DRUG
73
Bright Minds Biosciences
DRUG
$495M
-206,427
EYPT icon
74
EyePoint Pharmaceuticals
EYPT
$1.2B
-3,181,818
GKOS icon
75
Glaukos
GKOS
$6.07B
-190,256